Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ESR1 | P03372 | 1/20 | 0.68 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.68 |
| ▸ | PKM | P14618 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | HTT | P42858 | 1/20 | 0.68 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.64 |
| ▸ | CES2 | O00748 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | MMP3 | P08254 | 2/20 | 0.61 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7108563 | 0.98 | RAB9A (0.96) | RAB9ALMNAMAPTMEN1KMT2A | |
| SCHEMBL17536704 | 0.98 | RAB9A (0.96) | RAB9ALMNAMAPTMEN1KMT2A | |
| Benzophenone SCHEMBL5719480 | 0.98 | RAB9A (0.95) | RAB9ALMNAMAPTMEN1KMT2A | |
| Methyl Alcohol SCHEMBL27534896 | 0.96 | RAB9A (0.92) | RAB9ALMNAMAPTMEN1KMT2A | |
| SCHEMBL7929339 | 0.95 | MAPT (0.91) | RAB9ALMNAMAPTMEN1KMT2A | |
| Biphenyl SCHEMBL7692075 | 0.93 | RAB9A (0.87) | RAB9ALMNAMAPTMEN1KMT2A | |
| SCHEMBL124916 | 0.93 | MEN1 (0.86) | RAB9ALMNAMAPTMEN1KMT2A | |
| SCHEMBL9400453 | 0.93 | MEN1 (0.86) | RAB9ALMNAMAPTMEN1KMT2A | |
| Benzophenone SCHEMBL27537831 | 0.93 | MEN1 (0.86) | RAB9ALMNAMAPTMEN1KMT2A | |
| SCHEMBL7938553 | 0.93 | MEN1 (0.86) | RAB9ALMNAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494396-B1 | CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF | PIERCE BIOTECHNOLOGY INC (US) | 2025-06-11 | — | — | EP | claimed |
| US-10722882-B2 | Chemiluminescent and fluorescent substrate pads and uses thereof | PIERCE BIOTECHNOLOGY, INC. (US) | 2020-07-28 | — | — | US | claimed |
| EP-3494396-A1 | CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF | Pierce Biotechnology, Inc. (US) | 2019-06-12 | — | — | EP | claimed |
| US-20180043355-A1 | CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF | PIERCE BIOTECHNOLOGY, INC. | 2018-02-15 | — | — | US | claimed |
| WO-2018027004-A1 | CHEMILUMINESCENT AND FLUORESCENT SUBSTRATE PADS AND USES THEREOF | PIERCE BIOTECHNOLOGY, INC. (US) | 2018-02-08 | — | — | WO | claimed |
| US-20150148292-A1 | BONE MORPHOGENETIC PROTEIN PATHWAY ACTIVATION, COMPOSITIONS FOR OSSIFICATION, AND METHODS RELATED THERETO | UNIV EMORY (US) | 2015-05-28 | — | — | US | claimed |
| WO-2014011540-A1 | BONE MORPHOGENETIC PROTEIN PATHWAY ACTIVATION, COMPOSITIONS FOR OSSIFICATION, AND METHODS RELATED THERETO | EMORY UNIVERSITY (US) | 2014-01-16 | — | — | WO | claimed |
| WO-2006076034-A2 | STABILIZED TWO COMPONENT SYSTEM FOR CHEMILUMIESCENT ASSAY IN IMMUNODIAGNOSTICS | BHANU, KALRA (US) | 2006-07-20 | — | — | WO | claimed |
| EP-1254252-A4 | NOVEL STABILIZED FORMULATIONS FOR CHEMILUMINESCENT ASSAYS | GIRI BRIJ P (US) | 2006-06-07 | — | — | EP | claimed |
| US-20050272108-A1 | Stabilized two component system for chemiluminescent assay in immunodiagnostics | KALRA BHANU | 2005-12-08 | — | — | US | claimed |
| US-20010046688-A1 | Novel stabilized formulations for chemiluminescent assays | GIRI BRIJ PAL (US) | 2001-11-29 | — | — | US | claimed |
| WO-2001055446-A1 | NOVEL STABILIZED FORMULATIONS FOR CHEMILUMINESCENT ASSAYS | GIRI BRIJ PAL (US) | 2001-08-02 | — | — | WO | claimed |
| EP-0692033-B1 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BRITISH TECH GROUP (GB) | 1998-03-11 | — | — | EP | claimed |
| US-5512451-A | MIXTURE OF A AROMATIC DIACYL CYCLIC HYDRAZIDE, PEROXIDASE CATALYST AND OXIDIZER | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1996-04-30 | — | — | US | claimed |
| EP-0692033-A1 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BTG INTERNATIONAL LIMITED (GB) | 1996-01-17 | — | — | EP | claimed |
| WO-1994023060-A2 | ENHANCEMENT OF CHEMILUMINESCENT REACTIONS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1994-10-13 | — | — | WO | claimed |
| EP-0210449-B1 | PROLONGED CHEMILUMINESCENCE | MILES INC. (US) | 1993-07-28 | — | — | EP | claimed |
| US-4950588-A | DETECTION OF NUCLEIC ACID HYBRIDS, ANTIBODIES ANTIGENS | MOLECULAR DIAGNOSTICS, INC. (US) | 1990-08-21 | — | — | US | claimed |
| EP-0210449-A2 | Prolonged chemiluminescence | MILES INC. (US) | 1987-02-04 | — | — | EP | claimed |
| EP-0116454-A2 | Enhanced luminescent or luminometric assay | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1984-08-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150148292-A1 | BONE MORPHOGENETIC PROTEIN PATHWAY ACTIVATION, COMPOSITIONS FOR OSSIFICATION, AND METHODS RELATED THERETO | BMP4, BMP2, BMP1 | RAB9A 2934/4885LMNA 1054/4885MAPT 4836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.